Cidara
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Cidara and buy or sell other stocks, ETFs, and their options commission-free!About CDTX
Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system.
CEOJeffrey L. Stein
CEOJeffrey L. Stein
Employees38
Employees38
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees38
Employees38
CDTX Key Statistics
Market cap370.04M
Market cap370.04M
Price-Earnings ratio-18.79
Price-Earnings ratio-18.79
Dividend yield—
Dividend yield—
Average volume1.06M
Average volume1.06M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$221.42
52 Week high$221.42
52 Week low$15.22
52 Week low$15.22
Stock Snapshot
As of today, Cidara(CDTX) shares are valued at $11.77. The company's market cap stands at 370.04M, with a P/E ratio of -18.79.
On 2026-01-08, Cidara(CDTX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.06M.
Over the past 52 weeks, Cidara(CDTX) stock has traded between a high of $221.42 and a low of $15.22.
Over the past 52 weeks, Cidara(CDTX) stock has traded between a high of $221.42 and a low of $15.22.
People also own
Based on the portfolios of people who own CDTX. This list is generated using Robinhood data, and it’s not a recommendation.